Brazil approves commercial use of genetically modified eucalyptus

Pulp & Paper Canada
April 15, 2015
By Pulp & Paper Canada
An example of plantation harvesting of eucalyptus. Courtesy of The Campaign to STOP GE Trees.
An example of plantation harvesting of eucalyptus. Courtesy of The Campaign to STOP GE Trees.

Brazil has become the first jurisdiction worldwide to permit the commercial use of FuturaGene’s genetically engineered eucalyptus. The Brazilian National Technical Commission on Biosafety (CTNBio) approved the commercial use of the yield-enhanced eucalyptus developed by FuturaGene. According to the company, field experiments conducted since 2006 at various locations in Brazil have demonstrated an approximate 20% increase in yield compared to its equivalent conventional variety.

The company says this approval represents the most significant productivity milestone for the renewable plantation forest industry since the adoption of clonal technology in the early 1990s. This approval enables the production of more fiber using less resources.

An impact study produced last year by Pöyry Silviconsult forecasts the potential gains of applying the genetically engineered eucalyptus technology to the entire Brazilian eucalyptus plantation area by the year 2050. It concludes that this variety of eucalyptus will be ready to harvest in 5.5 years compared with the seven-year harvest of conventional eucalyptus on Brazilian forestry plantations. Consequently, it will require 13% fewer hectares to meet the same wood demand as existing crops.  

The decision of CTNBio is opposed by The Campaign to STOP GE Trees. That group quotes geneticist Dr. Ricarda Steinbrecher, co-director of EcoNexus and member of the Federation of German Scientists, who explains that GE trees are likely to cross national borders due to their large-scale dispersion of reproductive material. This, she points out, violates the 2008 decision on GE trees made by the UN Convention on Biological Diversity, to which Brazil is a signatory.

"A review of the scientific literature shows that currently no meaningful and sufficient risk assessment of GE trees is possible. Both scientific literature and in-field experience show that contamination by and dispersal of GE trees will take place," Steinbrecher added.

FuturaGene states that its yield-enhanced eucalyptus has been under development since 2001 and has undergone extensive biosafety assessment prior to submission for commercial approval. According to Dr. Stanley Hirsch, FuturaGene CEO, the company has several additional products at different stages of development in its pipeline. “This approval by CTNBio is an incentive for us to continue seeking innovative technological solutions that contribute for meeting the ever growing global demand for wood in a sustainable manner.”

FuturaGene is a wholly owned subsidiary of Suzano Pulp and Paper, one of the largest vertically integrated eucalyptus forestry, pulp and paper producers in Latin America. The two companies will next expand the field testing of the yield-enhanced eucalyptus “in a graded and responsible manner.”

Add comment

Disclaimer
Note: By submitting your comments you acknowledge that Pulp and Paper Canada has the right to reproduce, broadcast and publicize those comments or any part thereof in any manner whatsoever. Please note that due to the volume of e-mails we receive, not all comments will be published and those that are published will not be edited. However, all will be carefully read, considered and appreciated.


Security code
Refresh

Subscription Centre

 
New Subscription
 
Already a Subscriber
 
Customer Service
 
View Digital Magazine Renew

Most Popular

Latest Events

Paper2019
March 24-26, 2019
PaperCon 2019
May 5-8, 2019

We are using cookies to give you the best experience on our website. By continuing to use the site, you agree to the use of cookies. To find out more, read our Privacy Policy.